Figure 5From: Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case reportBrain MRI scans of the AMN patient: T2 weighted one month before DHA treatment began (September 2008) (left) and T2 weighted six months after DHA treatment began (March 2009) (right).Back to article page